Apravet 552 000 IU/g powder for use in drinking water/milk for pigs, calves, chickens and rabbits
Apravet 552 000 IU/g powder for use in drinking water/milk for pigs, calves, chickens and rabbits
Authorised
- Apramycin sulfate
Product identification
Medicine name:
Apravet 552 000 IU/g powder for use in drinking water/milk for pigs, calves, chickens and rabbits
Apravet 552 000 IE/g Pulver zum Eingeben über das Trinkwasser/ die Milch Schweine, Kälber, Hühner und Kaninchen
Active substance:
- Apramycin sulfate
Target species:
-
Pig (weaned piglet)
-
Rabbit
-
Cattle (pre-ruminant)
-
Chicken (broiler)
Route of administration:
-
In drinking water/milk use
Product details
Active substance and strength:
-
Apramycin sulfate1.00/milligram(s)1.00milligram(s)
Pharmaceutical form:
-
Powder for use in drinking water/milk
Withdrawal period by route of administration:
-
In drinking water/milk use
-
Pig (weaned piglet)
-
Meat and offal0day
-
-
Rabbit
-
Meat and offal0day
-
-
Cattle (pre-ruminant)
-
Meat and offal28day
-
-
Chicken (broiler)
-
Meat and offal0day
-
Eggsno withdrawal periodEggs: Not for use in birds producing or intended to produce eggs for human consumption. Do not use within 4 weeks of the start of the laying period.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QA07AA92
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Available in:
-
Germany
Package description:
- 1 Sachet with 1,812g
- box containing 50 sachets of 1,812 g
- box containing 25 sachets of 1,812 g
- bottle containing 90,58 g
- bag containing 1811,6 g
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
- Biovet AD
Responsible authority:
- Federal Office Of Consumer Protection And Food Safety
Authorisation number:
- 402305.00.00
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0252/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
France
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Malta
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 21/12/2023
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 26/01/2026
eu-PUAR-esv0252001-dcp-apravet-soluble-powder-en.pdf
English (PDF)
Download Published on: 21/12/2023